1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Antacids Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Antacids Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Antacids Market Regional Analysis
6.2 Middle East and Africa Antacids Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Antacids Market Forecast Analysis
7. Middle East and Africa Antacids Market Analysis – by Dosage Form
7.1 Tablet
- 7.1.1 Overview
- 7.1.2 Tablet: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Liquid
- 7.2.1 Overview
- 7.2.2 Liquid: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Middle East and Africa Antacids Market Analysis – by Drug Class
8.1 Proton Pump Inhibitors
- 8.1.1 Overview
- 8.1.2 Proton Pump Inhibitors: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 H2 Antagonist
- 8.2.1 Overview
- 8.2.2 H2 Antagonist: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Acid Neutralizers
- 8.3.1 Overview
- 8.3.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Middle East and Africa Antacids Market Analysis – by Distribution Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Retail Pharmacy
- 9.2.1 Overview
- 9.2.2 Retail Pharmacy: Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Online Pharmacy
- 9.3.1 Overview
- 9.3.2 Online Pharmacy : Middle East and Africa Antacids Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Middle East and Africa Antacids Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East and Africa Antacids Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Middle East and Africa Antacids Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
- 10.2.1.1.2 South Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
- 10.2.1.1.3 South Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
- 10.2.1.2 Saudi Arabia:
Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Dosage Form
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Drug Class
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
- 10.2.1.3 UAE:
Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Antacids Market Breakdown, by Dosage Form
- 10.2.1.3.2 UAE: Middle East and Africa Antacids Market Breakdown, by Drug Class
- 10.2.1.3.3 UAE: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
- 10.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Bayer AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GlaxoSmithKline plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sanofi
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Pfizer Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Procter & Gamble
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations